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ABSTRACT 25 
The fetus is thought to be protected from exposure to foreign antigens, yet CD45RO+ T cells reside in 26 
the fetal intestine. Here we combined functional assays with mass cytometry, single-cell RNA-27 
sequencing and high-throughput T cell antigen receptor (TCR) sequencing to characterize the CD4+ T 28 
cell compartment in the human fetal intestine. We identified 22 CD4+ T cell clusters, including naive-29 
like, regulatory-like and memory-like subpopulations, which were confirmed and further 30 
characterized at the transcriptional level. Memory-like CD4+ T cells had high expression of Ki-67, 31 
indicative of cell division, and CD5, a surrogate marker of TCR avidity, and produced the cytokines 32 
IFN-γ and IL-2. Pathway analysis revealed a differentiation trajectory associated with cellular 33 
activation and proinflammatory effector functions, and TCR repertoire analysis indicated clonal 34 
expansions, distinct repertoire characteristics and interconnections between subpopulations of 35 
memory-like CD4+ T cells. Imaging-mass cytometry indicated that memory-like CD4+ T cells 36 
colocalized with antigen-presenting cells. Collectively, these results provide evidence for the 37 
generation of memory-like CD4+ T cells in the human fetal intestine that is consistent with exposure 38 
to foreign antigens. 39 
 40 
Adaptive immunity is founded on the selection and expansion of antigen-specific T cells from 41 
a clonally diverse pool of naive precursors1. Naive T cells recirculate among lymph nodes to survey 42 
the array of peptide epitopes bound to major histocompatibility complex (MHC) proteins on the 43 
surface of antigen-presenting cells (APCs), and functional recognition of a given peptide-MHC 44 
molecule is governed by various danger signals and specific engagement via the clonotypically 45 
expressed T cell antigen receptor (TCR). This triggers a program of differentiation and proliferation 46 
that results in the generation of effector T cells, which home to the site of the primary infection and 47 
contribute to pathogen clearance, and memory T cells, which remain in the circulation and mediate 48 
anamnestic responses to secondary infection. In the last decade, it has also become clear that tissue-49 
resident T cells are commonly present at barrier sites, including the intestine2. 50 
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Fundamental knowledge of adaptive immunity during early life remains sparse. The infantile 51 
intestine is known to harbor clonally expanded T cells3, which were also identified in the human fetal 52 
intestine, but rarely in fetal mesenteric lymph nodes, fetal thymus or fetal spleen, suggesting 53 
compartmentalization4. In addition, a rare population of CD4+ T cells displaying a memory and 54 
proinflammatory phenotype has been identified in umbilical cord blood5. Although the dogma of a 55 
sterile womb has been challenged by reports of bacteria colonization in the placenta6,7, amniotic 56 
fluid8,9 and meconium10, others have questioned these results11. Here we have combined functional 57 
studies with mass cytometry, RNA-sequencing (RNA-seq) and high-throughput TCR-sequencing to 58 
perform an in-depth analysis of the fetal intestinal CD4+ T cell compartment. Our results provide 59 
evidence for memory formation in the human fetal intestine, consistent with in utero exposure to 60 
foreign antigens.  61 
 62 
RESULTS 63 
Human fetal intestinal CD4+ T cells are phenotypically diverse 64 
To explore the CD4+ T cell compartment in the human fetal intestine, we applied a mass 65 
cytometry panel comprising 35 antibodies (Supplementary Table 1) that was designed to capture the 66 
heterogeneity of the immune system to seven lamina propria samples aged 14-21 gestational weeks12. 67 
After data acquisition, we selected CD45+ immune cells (Supplementary Fig. 1a) and mined the 68 
dataset via hierarchical stochastic neighbor embedding (HSNE)13. At the overview level, HSNE 69 
landmarks depicted the general composition of the immune system, with clear separation of the CD4+ 70 
T cell lineage (Supplementary Fig. 1b). We identified 110,332 CD4+ T cells, with an average of 71 
15,761 events per fetal intestine, comprising 47.9% ± 9.6% of all immune cells. We then subjected 72 
HSNE-defined CD4+ T cells (Supplementary Fig. 1b) to t-distributed stochastic neighbor embedding 73 
(t-SNE)14 in Cytosplore15 to project their marker expression profiles onto a two-dimensional graph 74 
(Fig. 1a and Supplementary Fig. 1c). CD4+ T cells were characterized as CD45+CD3+CD4+CD7+ (Fig. 75 
1a). Moreover, all CD4+ T cells were positive for the tissue-resident marker CD38 and approximately 76 
50% of cells expressed CD161. 24.1% of the CD4+ T cell population co-expressed CD27, CD28, 77 
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CD45RA and CCR7, indicative of a naive T cell (TN) phenotype, whereas 64.5% expressed CD45RO, 78 
indicative of a memory T cell (TM) phenotype (Fig. 1a,b). While all CD45RO+ TM cells were CD28+, 79 
differential expression of CD25, CD27, CD103, CD117, CD127, CCR6 and CCR7 was observed on 80 
these cells (Fig. 1a,b), reflecting substantial phenotypic diversity.  81 
We next applied Gaussian mean-shift clustering to the mass cytometry data using the t-SNE 82 
coordinates of the embedded CD4+ T cells (Fig. 1a). Based on cell density features (Fig. 1c), this 83 
identified 22 distinct CD4+ T cell clusters (Fig. 1d), each defined by a unique marker expression 84 
profile. Hierarchical clustering of the heatmap revealed eight major groups (CD161+CCR6–CD117– 85 
TM cells, CD161+CCR6+CD117+ TM cells, DN TM cells, Treg cells, CD161–CCR7+ TM cells, CD161– 86 
TN cells, CD161lo TN/TM cells and CD161–CCR7– TM cells) (Fig. 1e). High expression of CD25 and a 87 
lack of CD127 distinguished two regulatory T (Treg) cell clusters, with either a CD45RA+ TN or a 88 
CD45RO+ TM phenotype (Fig. 1a,b,e). CD161+CD4+ T cells branched into a CCR6–CD117–CD45RO+ 89 
TM and a CCR6+CD117+CD45RO+ TM cluster (Fig. 1e). Moreover, CD45RA+ TN and CD45RO+ TM 90 
cells were detected in both the CD161– and the CD161lo subpopulations. Additional diversity was 91 
observed for the expression of several activation markers, including CRTH2, HLA-DR, KLRG-1 and 92 
PD-1, the latter especially within the CD45RO+ TM cell clusters (Supplementary Fig. 1c). Of note, a 93 
small population of CD4–CD8a–TCRγδ– (DN) TM cells clustered among CD4+ T cells in both the 94 
HSNE and t-SNE plots. Biaxial plots confirmed coexpression of CD45RA and CCR7 on TN cells 95 
(Fig. 1f), whereas the CD161lo/–CD45RO+ TM subpopulation contained both CCR7+ central memory T 96 
(TCM) cells and CCR7– effector memory T (TEM) cells (Fig. 1f). All other CD45RO+ TM 97 
subpopulations harboured primarily TEM cells. Quantification of cellular frequencies for the CD4+ T 98 
cell clusters per fetal intestine revealed highly similar compositions with all CD45RO+ TM clusters 99 
detectable in all samples (Fig. 1g). In contrast, parallel analyses of CD4+ T cells isolated from three 100 
fetal livers and three fetal spleens from one shared and two additional fetuses aged 16-21 gestational 101 
weeks revealed a predominance of CD45RA+ TN cells (Supplementary Fig. 2a,b). These results 102 
delineated a phenotypically diverse array of human fetal intestinal CD4+ T cells, most of which 103 
displayed features associated with antigen exposure. 104 
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 105 
Fetal CD4+ T cells display a memory gene expression profile  106 
We next performed single-cell RNA-seq on flow-sorted fetal intestinal CD4+ cells from a 107 
lamina propria sample that was also included in the mass cytometry analysis. This yielded data for 108 
1,804 CD4+ T cells, identifying cell-specific variable expression of 2,174 genes (Methods), which 109 
were further analyzed using the Seurat computational pipeline16. Unsupervised clustering revealed 110 
nine transcriptionally distinct subpopulations, seven of which corresponded to CD3+ T cell subsets 111 
while two displayed a gene expression profile matching CD86+HLA-DR+ APCs. The corresponding 112 
gene expression profiles of the seven T cell subsets were projected onto a single graph using t-SNE 113 
(Fig. 2a), and the top 20 upregulated genes were displayed in a heatmap (Fig. 2b). Five of the seven 114 
RNA-seq-identified CD4+ T cell subpopulations corresponded to the mass cytometry-defined CD4+ T 115 
cell major groups: CCR7+ TN with CD45RA+ TN, KLRB1lo/–SELL– TM with CD161lo/–CD45RO+ TM, 116 
KLRB1+CCR6–SELL– TM with CD161+CCR6–CD45RO+ TM, KLRB1+CCR6+SELL– TM with 117 
CD161+CCR6+CD45RO+ TM and FOXP3+ Treg cells with CD25+CD127lo Treg cells. The mass 118 
cytometry defined CD161– and CD161lo subpopulations (Fig. 1e) could not be discriminated in the 119 
RNA-seq dataset. One additional RNA-seq-identified subpopulation corresponded to proliferating 120 
cells, based on the expression of genes associated with cell division (CCNB2, CDK1 and MKI67) 121 
(Fig. 2a,b).  122 
As CD45RA and CD45RO were not detectable, we used other markers to distinguish TM from 123 
TN clusters. To compare gene or marker expression among cell clusters, we used violin plots, 124 
displaying the mode average as the thickest section (Fig. 2c-e). Consistent with the mass cytometry 125 
data, RNA-seq-defined TN cells were KLRB1–CCR7+SELL+/– (Fig. 2c,d), the latter confirmed by flow 126 
cytometry (Fig. 2e and Supplementary Fig. 3a). In the absence of TM-associated markers, SELL– TM 127 
cell populations were identified on the basis of differential expression of KLRB1 and CCR6 (Fig. 128 
2c,d). Consistent with the mass cytometry data, expression of KIT (CD117) was restricted primarily to 129 
KLRB1+CCR6+SELL– TM cells (Supplementary Fig. 3b). Moreover, the gene expression profile of the 130 
IL2RA+IL7RloFOXP3+ Treg cell population (Fig. 2c) corresponded to the mass cytometry-defined 131 
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CD25+CD127lo Treg cells (Fig. 2d). In addition, several RNA-transcripts including LAG3, TIGIT, 132 
CTLA4 and TNFRSF18 (GITR) ascertained the identity of FOXP3+ Treg cells (Fig. 2b). Finally, the 133 
RNA-seq data revealed an undefined TM cluster that was not identified by mass cytometry, but 134 
expressed genes similar to those detected in the KLRB1+CCR6+SELL– TM subpopulation, such as 135 
CD69, CCL5 and JAML. Cell population frequencies identified by mass cytometry and RNA-seq were 136 
comparable with the exception of mass cytometry-defined CD25+CD127lo Treg cells and RNA-seq-137 
defined FOXP3+ Treg cells (Supplementary Fig. 3c).  138 
Compared with the CCR7+ TN population, KLRB1lo/–SELL– TM, KLRB1+CCR6–SELL– TM, 139 
KLRB1+CCR6+SELL– TM and undefined TM subpopulations had high expression of the tissue-resident 140 
and activation-associated gene CD69, the differentiation-promoting gene ANXA1 (Annexin A1), the 141 
chemokine-like factor CKLF, the cytokine IL32, the proliferation-associated gene JUN (C-Jun) and 142 
the adhesion molecule JAML (Fig. 3a). CD40LG (CD154), TNFSF14 and TGFB1 were specifically 143 
upregulated by KLRB1+CCR6–SELL– TM, KLRB1+CCR6+SELL– TM and undefined TM clusters, while 144 
CCL5 and MAP3K8 kinase upregulated by KLRB1+CCR6–SELL– TM and undefined TM 145 
subpopulations. Moreover, IL4I1 was specifically expressed by KLRB1+CCR6+SELL– TM and 146 
undefined TM cells. In addition, all fetal SELL– TM subpopulations had high expression of the tissue-147 
resident genes ITGAE (CD103) and/or CD38 (Fig. 3a).  148 
In agreement with the RNA-seq data, flow cytometry indicated that the activation markers 149 
CXCR3, CCR4, CD69 and CD226 were highly expressed on CCR7– TEM cells (Fig. 3b). All CD4+ T 150 
cells expressed CD95, with the highest expression on CD161+ TEM cells (Fig. 3b). Expression of 151 
CD31, a marker associated with recent thymic emigrants17, was highest on CD45RA+ TN cells (Fig. 152 
3b). Thus, RNA-seq confirmed the existence of distinct subpopulations of CD4+ T cells and indicate 153 
that many genes associated with inflammation and tissue residency were upregulated by fetal CD4+ 154 
TM cells, consistent with antigen-driven functionality and maturation. 155 
 156 
Computational analysis reveals a differentiation pathway of CD4+ T cells 157 
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We next visualized the evolution of the t-SNE computation of the mass cytometry and RNA-158 
seq data to reveal the ordering of single cells along putative differentiation trajectories12,15. At the 159 
onset of the mass cytometry data computation, where cells are grouped based on major shared 160 
features, CD25+CD127lo Treg cells clustered separate from the other cells, whereas the other cell 161 
clusters were ordered in a linear fashion with the CD45RA+ TN cells next to the CD161lo/–CD45RO+ 162 
TM cells, followed by the CD161+CCR6–CD45RO+ TM cells and the CD161+CCR6+CD45RO+ TM 163 
cells, consecutively (Fig. 4a). A similar phenotypic ordering was observed in parallel analyses of the 164 
RNA-seq data, although the KLRB1+CCR6+SELL– TM subpopulation aligned differently, but remained 165 
connected with the KLRB1+CCR6–SELL– TM cluster (Fig. 4b). Individual marker expression patterns 166 
at the middle of the t-SNE computation validated the ordering of the clusters and the comparability of 167 
the mass cytometry and RNA-seq data (Supplementary Fig. 4a,b). Similar patterns were identified 168 
using Diffusion map18, VorteX19 and principal component analysis (PCA)20 (Supplementary Fig. 4c–169 
f). Thus, this analysis reveals a putative differentiation pathway leading to TM formation. 170 
To extend our analysis of the gene expression profiles underlying this putative differentiation 171 
trajectory, we used the pseudotime algorithm in the Monocle toolkit21,22, which calculates the ordering 172 
of individual cells based on single-cell expression profiles. Based on this analysis, CCR7+ TN cells 173 
were separated from SELL– TM cells (Fig. 4c). When we clustered genes according to expression 174 
patterns along the pseudotime trajectory, cell-to-cell transitioning could be explained by the kinetics 175 
of 1,376 variable genes, which formed three large modules (Fig. 4d). The first module contained 540 176 
genes associated with CCR7+ TN cells, including SELL, CCR7, CD27 and CD28 (Fig. 4d). The second 177 
module contained 453 genes, many of which were associated with an ongoing transcriptional 178 
program, such as RPL21, RPS2 and RPLP1. The highest activity of this transcriptional gene 179 
expression profile coincided with the transition of cells with a CCR7+ TN phenotype into cells with a 180 
SELL– TM phenotype (Fig. 4c,d). The third module contained 383 genes (Fig. 4d), 106 of which were 181 
associated with cellular activation and regulation of the immune system (Supplementary Fig. 5a), 182 
while 133 encoded proteins known to interact physically with each other (Supplementary Fig. 5b). In 183 
addition, 23 genes in module 3 could be assigned to cytokine or chemokine receptor pathways, 184 
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including CCL20 and its receptor CCR6, the interferon receptor IFNGR1, TNF family members and 185 
IL-1 and IL-17 receptors (Supplementary Fig. 5b). Several signaling cascades were also represented 186 
in module 3, including the MAPK, TNF, IL-17 and TCR signaling pathways (FYN, LCP2, SOS1, 187 
MAP3K8 kinase, FASL and TNF) (Fig. 4d). The TH17-associated gene RORC was expressed in 188 
module 3 (Fig. 4d). In addition, the dynamic expression profiles of FYN, FASL and TNF clustered 189 
tightly with KLRB1 (CD161) (Fig. 4d) at the point in the pseudotime trajectory where CCR7+ TN cells 190 
were aligned next to SELL– TM cells (Fig. 4d). Finally, we quantified the smoothness of cell-to-cell 191 
transitioning based on gene expression changes along the trajectory, which showed that the 192 
pseudotime trajectory was most uncertain at the beginning and toward the end, but quite robust in the 193 
middle, where CCR7+ TN cells were aligned next to SELL– TM cells (Fig. 4d). In sum, these results 194 
identified temporal patterns of gene expression along the single-cell trajectory that is compatible with 195 
the transition of cells displaying a TN phenotype into cells with a TM phenotype.  196 
 197 
TCR analysis reveals clonal expansion of fetal CD4+ T cells  198 
 Surface expression of CD5 correlates with TCR avidity23–26. Because CD5 gene expression 199 
was upregulated in TM cells compared to TN cells, we quantified CD5 expression on all identified fetal 200 
intestinal CD4+ T cell subsets using flow cytometry and observed that all the CD4+ T cell subsets 201 
expressed CD5 (Fig. 5a), but that the median fluorescence intensity (MFI) was higher in CD161– TM, 202 
CD161+CD117– TM and CD161+CD117+ TM cells and lower in CD25+CD127lo Treg cells and 203 
CD45RA+ TN cells (Fig. 5a–c), suggesting that cells with a TM phenotype express TCR with a higher 204 
avidity compared to TN cells.  205 
Next, we evaluated the TCR clonotypic architecture of flow-sorted fetal intestinal CD45RA+ 206 
TN, CD45RO+ TM and CD25+CD127lo Treg subpopulations. Analysis of the TCRβ rearrangements in a 207 
single fetal intestine indicated limited overlap among the distinct subpopulations, most of which were 208 
highly polyclonal (not shown). Distinct clonotypes were expanded among CD45RO+ TM cells 209 
compared to CD45RA+ TN cells (Supplementary Fig. 6a). We then used a quantitative high-210 
throughput approach for deep sequencing of TCRα and TCRβ rearrangements in all identified fetal 211 
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intestinal CD4+ T cell subsets isolated from two additional fetal intestines (Supplementary Table 2). 212 
Post-analysis of the obtained repertoires was conducted using VDJtools27. As expected, all TM 213 
subpopulations showed greater clonality compared to the TN subpopulation (Fig. 5d,e). The averaged 214 
characteristics of CDR3 length, added N-nucleotides and physicochemical characteristics of the 5 215 
amino acid residues located in the middle of the CDR3 loop, which are most likely to contact the 216 
peptide-MHC complex28, also differed among all subpopulations (Fig. 5f). The latter analysis 217 
included the averaged statistical potential of the CDR3 loop with respect to epitope interactions, 218 
comprising the estimated “energy” of the interaction with a random epitope29, the “strength” of the 219 
interaction (derivative of “energy”, VDJtools27), hydrophobicity (Kidera factor 4)30,31 and “volume” 220 
(values from http://www.imgt.org/IMGTeducation/Aide-221 
memoire/_UK/aminoacids/IMGTclasses.html). These analyses provided no evidence for clonal 222 
expansion of CD4+ T cells as a function of intrinsically high TCR-avidities for self-derived peptide-223 
MHC complexes (Fig. d-f), suggesting indirectly that antigen-specific interactions triggered clonal 224 
selection of CD4+ T cells from the TN cell pool. Analysis of V-J segment use (Jensen-Shannon 225 
divergence; Supplementary Fig. 6b) and overlaps among repertoires in terms of the weighted 226 
proportion of shared TCRβ clonotypes revealed tightly clustered technical replicates and clearly 227 
distinguished all subpopulations of CD4+ T cells (Fig. 5g). At the same time, the CD161– TM, 228 
CD161+CD117– TM and CD161+CD117+ TM cells clustered similarly in each fetus, with minimum 229 
overlap with the CD45RA+ TN and CD25+CD127lo Treg cells (Fig. 5g). Analysis of the clonal overlap 230 
of amino acid CDR3 repertoires between the same populations in the two fetal intestines revealed that 231 
the CD161– TM, CD161+CD117– TM and CD161+CD117+ TM populations displayed much stronger 232 
overlap than the CD45RA+ TN and CD25+CD127lo Treg CD4+ T cells (Supplementary Fig. 6c), which 233 
could be explained by TCR selection due to exposure to similar foreign antigens. Finally, although the 234 
majority of the TCR repertoire was specific for each population, up to 20% of the T cell clones were 235 
shared between the CD45RA+ TN and the three CD45RO+ TM cell populations (Supplementary Fig. 236 
6d), suggesting a potential clonal relationship between CD45RA+ TN and CD45RO+ TM cells. These 237 
results indicate that avidity-based, clonotype-specific expansion of the TN pool was associated with 238 
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TM formation and confirmed the close relationship between CD161– TM, CD161+CD117– TM and 239 
CD161+CD117+ TM cells. 240 
 241 
Fetal CD4+ TM cells secrete proinflammatory cytokines  242 
To determine the functional profiles of fetal intestinal CD4+ T cells, we flow-sorted CD3+CD4+ T 243 
cells and measured expression of TNF, IL-2, IFN-γ, IL-4, granzyme B and IL-17A in CD45RA+ TN 244 
cells and CD117– and CD117+ TM cells after cross-linking CD3 and CD28. The activation marker 245 
CD154 (CD40L) was upregulated on all cells analyzed (Fig. 6a,b), indicating efficient stimulation. All 246 
three subpopulations secreted large amounts of TNF (Fig. 6a,b), but CD117– TM cells and CD117+ TM 247 
cells displayed the highest MFIs (Supplementary Fig. 7a). Moreover, IL-2, IFN-γ, IL-4 and granzyme 248 
B were more commonly expressed in CD117– TM and CD117+ TM cells relative to CD45RA+ TN cells 249 
(Fig. 6a,b). The majority of cytokine-producing CD4+ T cells did not express Ki-67 (Supplementary 250 
Fig. 7b). Importantly, higher frequencies of IL-2+IFN-γ+ cells were detected in the CD117– TM and 251 
CD117+ TM cells compared with the CD45RA+ TN population (Supplementary Fig. 7c), suggesting 252 
greater polyfunctionality. Although the TH17-associated RORC gene was expressed by 1.3% of 253 
KLRB1+CCR6+SELL– TM cells (Fig. 4d), IL-17A production was undetectable in all TM cells. Thus, 254 
fetal intestinal CD117– TM and CD117+ TM cells deployed multiple effector functions reminiscent of 255 
classical CD4+ TM cells in response to TCR-mediated signal transduction and costimulation via CD28. 256 
 257 
Fetal CD4+ T cells are co-localized with antigen presenting cells 258 
The single-cell RNA-seq analysis revealed a MKI67+ cluster of proliferating cells, together 259 
with high expression of the TM cell-associated markers KLRB1 (CD161) and CD69 and low 260 
expression of the TN cell-associated markers CCR7 and SELL (CD62L) (Fig. 7a). Flow cytometry of 261 
fetal intestinal CD4+ T cells indicated the presence of Ki-67+ cells, predominantly within the 262 
CD45RO+ compartment (Fig. 7b). To assess the spatial distribution of CD4+ T cells in situ, we 263 
employed a panel of 15 antibodies (Supplementary Table 3) combined with a DNA stain to perform 264 
imaging-mass cytometry on tissue sections of four human fetal intestinal samples. Stains for collagen 265 
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I and smooth muscle actin were used to visualize the extracellular matrix of the basement membrane, 266 
and the epithelium and lamina propria were distinguished as vimentin–E-cadherin+ and vimentin+E-267 
cadherin–, respectively (Fig. 7c,d). Most CD4+ T cells localized to the lamina propria (Fig. 7c,d). 268 
Differential expression of CD45RA further allowed discrimination of CD45RA+ TN (Fig. 7c,d) from 269 
CD45RA– TM cells in the lamina propria (Fig. 7c,d). In addition, all CD4+ T cells expressed CD38, 270 
whereas only some CD4+ T cells expressed CD69 (Fig. 7d). Using a second panel comprising 10 271 
antibodies (Supplementary Table 3), we found that CD4+ T cells frequently colocalized with 272 
CD163+HLA-DR+ APCs (Fig. 7e). Moreover, the single-cell RNA-seq analysis of fetal intestinal cells 273 
revealed two cluster of cells displaying high expression of gene transcripts encoding HLA-DR, CD74 274 
(HLA-class II invariant chain), CD80 and CD86, typically found in APCs. Moreover, these APCs 275 
expressed gene transcripts encoding the inhibitory molecule PD-L1 (CD274) and CD40, both 276 
consistent with an activated phenotype (Fig. 7f), whereas stimulated fetal intestinal CD4+ T cells 277 
expressed CD40L (CD154) (Fig. 6b). In addition, 25.8% of APCs had high expression of CCR7, 278 
potentially enabling migration to the mesenteric lymph nodes (Fig. 7f). Collectively, these results 279 
indicated the existence of CD4+ TM cells in the fetal intestine, many of which colocalized in the 280 
lamina propria with activated CD163+HLA-DR+ APCs. 281 
 282 
DISCUSSION 283 
Here we used mass cytometry and single-cell RNA-seq to characterize CD4+ T cells in the 284 
human fetal intestine. Mass cytometry revealed three major populations of fetal intestinal CD4+ T 285 
cells (TN, TM and Treg cells), that could be further distinguished into eight distinct cells clusters that 286 
displayed additional heterogeneity. These cell clusters were present in seven human fetal intestines, 287 
suggesting a physiologically robust immune composition. Single-cell RNA-seq revealed the presence 288 
of seven CD4+ T cell subpopulations, five of which displayed phenotypic overlap with the mass 289 
cytometry-defined CD4+ T cell subpopulations. We used computational tools to construct putative 290 
CD4+ T cell differentiation trajectories. Using adapted t-SNE32, we obtained remarkably similar 291 
trajectories for the mass cytometry and RNA-seq data. We identified three distinct gene expression 292 
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modules along the differentiation trajectory that correspond to an increase in gene translation and 293 
subsequent activation of immune related genes. In addition, high-throughput TCR sequencing 294 
indicated clonal expansions within the CD4+ TM cell pool, consistent with the evidence for cell 295 
proliferation within the CD45RO+ TM pool that was obtained at both the mRNA and protein level. 296 
Moreover, CD4+ TM cells secreted higher amounts of pro-inflammatory cytokines upon TCR 297 
triggering compared to CD4+ TN cells. Finally, fetal intestinal CD4+ TM cells displayed a tissue-298 
resident profile and were frequently found to colocalize with APCs in the lamina propria. Together, 299 
this suggested that clonotype-specific transcriptional programs regulated by antigen encounter 300 
underpinned the formation of CD4+ TM cells in the fetal intestine. 301 
T cells in umbilical cord and peripheral blood obtained of infants aged 2 months were 302 
reported to display a typical CD45RA+ TN phenotype3. The observation herein that a large pool of 303 
CD45RO+ cells with a tissue-resident profile populated the fetal intestine suggests the 304 
compartmentalization of the immune system early in life. In conjunction with the earlier finding that 305 
clonally expanded T cells were present in the fetal intestine, but virtually absent in other fetal organs4, 306 
our results further suggest that memory formation was driven by local exposure to foreign antigens. 307 
The observation that there is a substantial overlap in the amino acid CDR3 repertoires of the memory 308 
CD4+ T cells compartment in the two fetuses analyzed may indicate exposure to similar foreign 309 
antigens.  310 
 Approximately 50% of all fetal intestinal CD4+ T cells were CD161+ and transcriptionally 311 
distinct from their CD161– counterparts, consistent with a recent study33. The kinetics of KLRB1 312 
(CD161) expression was preceded by increased expression CD5 and coincided with increased 313 
expression of several TCR signaling genes, including FYN, FASL and TNF, suggesting a coordinated 314 
program of transcription. Of note, CD161 was identified as a costimulatory molecule in the context of 315 
TCR stimulation33. 316 
Although the mass cytometry and RNA-seq data were largely compatible, there were 317 
exceptions. For example, coexpression of CCR6 and KIT among KLRB1+CCR6+SELL– TM cells was 318 
not reflected in the gene expression profiles. Conversely, expression of ITGAE (CD103) mRNA was 319 
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not reflected by protein expression. These anomalies were likely attributable to discordant gene 320 
transcription and protein expression34 and may also relate to differences in sensitivity of the employed 321 
techniques. 322 
The presence of a large population of TN cells in the fetal intestine is in stark contrast to the 323 
predominace of TM cells in the adult intestine. As the TN cells expressed relatively high amounts of 324 
CD31, which demarcates recent thymic emigrants, our results indicate direct migration of recent 325 
thymic emigrants into the intestine35,36. We propose that antigen-specific priming of TN cells takes 326 
place in the mesenteric lymph nodes followed by migration of the resulting TM cells to the lamina 327 
propria leading to a progressive loss of TN cells. Similarly memory formation is taking place in the 328 
CD8+ T cell compartment (not shown).  329 
Distinct subpopulations of fetal intestinal Treg cells were distinguished by several markers, 330 
including high expression of CD25 and Foxp3, and a lack of CD127. In line with previous results37, 331 
approximately 50% of these cells expressed CD45RO, while the remainder expressed CD45RA. The 332 
CD45RA+ Treg cells expressed TCRs with longer CDR3β loops, higher numbers of added N-333 
nucleotides and distinct physicochemical characteristics, suggesting higher affinities for self-antigens 334 
compared to CD45RO+ Treg cells38. The presence of oligoclonal T cell expansions in fetuses with 335 
autoimmune conditions associated with a genetic absence of Treg cells indicate a key role for these 336 
cells in immune suppression in utero39.  337 
In conclusion, our study revealed a putative differentiation trajectory in the fetal intestinal 338 
CD4+ T cell compartment, consistent with the formation of TM cells in utero, presumably as a 339 
consequence of exposure to foreign antigens. These could include non-inherited maternal HLA-340 
molecules40 and pathogen-derived ligands, which could be derived from amniotic fluid8,9. We propose 341 
that immune priming in the fetal intestine prepares the infant for the massive influx of bacteria that 342 
occurs immediately after birth, with anamnestic responses in situ facilitated by the colocalization of 343 
CD4+ TM cells with APCs. 344 
 345 
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 459 
FIGURE LEGENDS 460 
Fig. 1: Mass cytometric analysis of fetal intestinal CD4+ T cells.  461 
a, t-SNE embedding of all CD4+ T cells (n = 110,332) derived from human fetal intestines (n = 7). 462 
Colors represent the ArcSinh5-transformed expression values of the indicated markers. b, t-SNE plot 463 
depicting the population cell border for TN cells (dashed yellow line), TM cells (dashed red line), and 464 
Treg cells (dashed green line). c, Density map describing the local probability density of cells, where 465 
black dots indicate the centroids of identified clusters using Gaussian mean-shift clustering. d, t-SNE 466 
plot showing cluster partitions in different colors. e, Heatmap showing median expression values and 467 
hierarchical clustering of markers for the identified subpopulations. f, Biaxial plots showing CD45RA 468 
and CCR7 expression on the indicated clusters analyzed by mass cytometry. The 22 clusters were 469 
merged into 6 phenotypic groups according to the heatmap shown in (e). g, Composition of the CD4+ 470 
T cell compartment in each fetal intestine represented by vertical bars, where the colored segment 471 
lengths represent the proportion of cells as a percentage of all CD4+ T cells in the sample. Colors as 472 
shown in (e). 473 
Fig. 2: Single-cell RNA-sequencing of fetal intestinal CD4+ T cells. 474 
a, t-SNE embedding of fetal intestinal CD4+ T cells (n = 1,804) showing seven transcriptionally 475 
distinct clusters, including CCR7+ TN (n = 358), KLRB1lo/–SELL– TM (n = 237), KLRB1+CCR6–SELL– 476 
TM (n = 640), KLRB1+CCR6+SELL– TM (n = 336), undefined TM (n = 101), FOXP3+ Treg cells (n = 71), 477 
and proliferating cells (n =61). Colors indicate different cell clusters. b, Heatmap showing the 478 
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normalized single-cell gene expression value (Z-Score, purple-to-yellow scale) for the top 20 479 
differentially upregulated genes in each identified cluster. Colors as shown in (a). c–e, Expression of 480 
the indicated genes in each identified cluster at (c) the RNA level (log-normalized) and (d,e) the 481 
protein level analyzed by (d) mass cytometry (CyTOF, ArcSinh5-transformed) or (e) flow cytometry, 482 
presented as violin plots. Dashed lines indicate background levels. Colors as shown in (a). 483 
Fig. 3: Targeted analysis of memory-like fetal intestinal CD4+ T cells. 484 
a, Expression (log-normalized) of the indicated genes in distinct CD4+ T cell clusters as determined 485 
by single-cell RNA-seq analysis, presented as violin plots. Colors indicate different cell clusters. b, 486 
Biaxial plots showing expression of CXCR3, CCR4, CD69, CD226, CD95, and CD31 vs. CCR7 on 487 
the indicated CD4+ T cell clusters analyzed by flow cytometry. Data represent two to three 488 
independent experiments. 489 
Fig. 4: Single-cell trajectory analysis of fetal intestinal CD4+ T cells. 490 
a–b, t-SNE embeddings of all fetal intestinal CD4+ T cells analyzed by (a) mass cytometry (n = 491 
10,436) and (b) single-cell RNA-seq (n = 1,743) at the onset and at the middle of the t-SNE 492 
computation. Colors indicate different cell clusters. c, A single-cell trajectory from the RNA-seq data 493 
(excluding Treg cells and proliferating cells) recovered by pseudotime analysis. Colors indicate 494 
different cell clusters as shown in (b). Grey arrows indicate three small branches. d, Three kinetic 495 
modules of pseudotime-dependent genes (n = 1,376) depicted in a log-variance-stabilized expression 496 
heatmap, indicating gene-enriched biological processes. Genes confirmed by mass cytometry and 497 
flow cytometry are denoted by black labels, and genes involved in TCR signalling are denoted by 498 
gray labels. The dashed grey box indicates the coordinated expression profile of TNF, FASL, and 499 
FYN. Euclidean distance values comparing gene expression profiles for each ordered pair of 500 
neighboring cells along the pseudotime trajectory are shown in the graph (right). 501 
Fig. 5: CD5 expression analysis and high-throughput TCR-sequencing of fetal intestinal CD4+ T 502 
cells. 503 
a–b, CD5 expression on the indicated CD4+ T cell clusters. (a) The biaxial plots depict one 504 
representative experiment, and (b) the bar graphs depict the median fluorescence intensity (MFI) of 505 
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CD5 expression for each cluster relative to the corresponding CD161+CD117– TM subpopulation in 506 
each fetal intestine (n = 7). Data represent six independent experiments. Error bars indicate mean ± 507 
SEM. *p < 0.05, Two-tailed Wilcoxon matched-pairs signed-ranks test. c, Expression (log-508 
normalized ) of CD5 gene transcripts in the indicated cell clusters, presented as violin plots. d, Dot 509 
plots showing the percentage of TCR cDNA molecules per unique TCRβ sequence in each cluster 510 
from each fetal intestine. Data are from two independent samples. A single duplicate is shown for 511 
samples with technical replicates. e, Dot plots showing the normalized Shannon-Wiener index for 512 
TCRα (TRA) and TCRβ (TRB) sequences in each cluster from each fetal intestine. Data are from two 513 
independent samples. f, Dot plots showing averaged TCR repertoire characteristics weighted per 514 
clonotype for each cluster. Data are from two independent samples. g, Dendrogram showing weighted 515 
clonal overlaps for TCRβ nucleotide sequences among clusters, analyzed using the F2 similarity 516 
metric in VDJtools. Colors indicate different fetal intestines. 517 
Fig. 6: Functional profiling of fetal intestinal CD4+ T cells. 518 
a–b, Purified fetal intestinal CD4+ T cells were treated with a control antibody or stimulated with 519 
anti-CD3 and anti-CD28 for 4 h. Intracellular expression of TNF, IL-2, IFN-γ, IL-4, granzyme B, 520 
and CD154 was determined for each subpopulation by flow cytometry. (a) The biaxial plots show 521 
data from one representative experiment after stimulation with anti-CD3 and anti-CD28, and (b) the 522 
bar charts show data for each subpopulation from each fetal intestine (TNF: n = 4 samples in two 523 
independent experiments; IL-2 and granzyme B: n = 3 samples in two independent experiments; IFN-524 
γ, IL-4 and CD154: n = 7 samples in four independent experiments). Error bars indicate mean ± SEM. 525 
*p < 0.05, **p <0.01, Kruskal-Wallis test with Dunn’s test for multiple comparisons. 526 
Fig. 7: Characterization and spatial localization of fetal intestinal CD4+ T cells and APCs. 527 
a, Expression (log-normalized) of the indicated genes in proliferating fetal intestinal CD4+ T cells, 528 
presented as violin plot. b, Biaxial plots showing expression of Ki-67 vs. CD45RO in the fetal 529 
intestinal CD4+ T cell compartment analyzed by flow cytometry. Data represent two independent 530 
experiments. c, Representative mass cytometry image of a fetal intestine showing the overlay of CD3 531 
(red), Ecadherin (green), and DNA (blue). Scale bar, 100 μm. d, Representative mass cytometry 532 
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images of fetal intestines showing expression of the indicated stromal markers, immune markers, Ki-533 
67 and DNA by the cells identified in (c). Yellow arrows: CD4+CD45RA+ TN cells; white arrows: 534 
CD4+CD45RA– TM cells. e, Representative mass cytometry images of a fetal intestine showing the 535 
overlay of CD3 (red), CD4(green), CD163 (cyan), and HLA-DR (blue). Scale bar, 50 μm. Colors and 536 
scale bars are similar in all three panels. Data in (b-d) represent four independent samples in four 537 
independent experiments. f, Expression (log-normalized) of the indicated genes in two clusters of 538 
APCs, presented as violin plots. CCR7– APCs (n = 49), CCR7+ APCs (n = 17). 539 
 540 
METHODS 541 
Sample processing and cell isolation  542 
Fetal tissues were obtained from elective abortions with informed consent. The gestational age ranged 543 
from 14 to 22 weeks. Intestines were separated from mesentery, cut into small pieces, embedded in 544 
optimal cutting temperature compound, and snap-frozen in isopentane. The remaining intestines were 545 
used for single-cell isolation as described previously12. Briefly, fetal intestines were cleared of 546 
meconium, cut into fine pieces, treated with 1 mM dithiothreitol (Fluka) for 2 x 10 min (replacing 547 
buffer) at room temperature (rT), and then incubated with 1 mM ethylenediaminetetraacetic acid 548 
(Merck) for 2 x 1 h (replacing buffer) at 37 °C under rotation to separate the epithelium from the 549 
lamina propria. To obtain single-cell suspensions from the lamina propria, the intestines were rinsed 550 
with Hank’s balanced salt solution (Thermo Fisher Scientific), incubated with 10 U/mL collagenase 551 
IV (Worthington) and 200 µg/mL DNAse I grade II (Roche Diagnostics) overnight at 37 °C, and 552 
filtered through a 70 µm nylon mesh. Isolated cells were then further purified with a Percoll gradient 553 
(GE Healthcare). Fetal liver and spleen tissues were cut into small pieces and filtered through a 70 µm 554 
nylon cell strainer and the immune cells were isolated with Ficoll-PaqueTM density gradient. All the 555 
isolated cells were stored in liquid nitrogen. Study approval was granted by the Medical Ethics 556 
Commission of Leiden University Medical Centre (protocol P08.087). All experiments were 557 
conducted in accordance with local ethical guidelines and the principles of the Declaration of 558 
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Helsinki. 559 
Cell suspension-mass cytometry 560 
Antibodies used for cell suspension-mass cytometry are listed in Supplementary Table 1. Purified 561 
antibodies lacking carrier protein were conjugated with metal reporters by using a MaxPar X8 562 
Antibody Labeling Kit (Fluidigm). Procedures for antibody staining and data acquisition were 563 
described previously41. Briefly, cells from fetal intestines were incubated with 5 µM Cell-ID 564 
Intercalator-103Rh (Fluidigm) for 15 min at rT and then stained with a cocktail of metal-conjugated 565 
antibodies for 45 min at rT. After washing, cells were incubated with 125 nM Cell-ID Intercalator-Ir 566 
(Fluidigm) in MaxPar Fix and Perm Buffer (Fluidigm) overnight at 4 °C. Data were acquired using a 567 
CyTOF 2TM mass cytometer (Fluidigm) and normalized using EQ Four Element Calibration Beads 568 
with the reference EQ Passport P13H2302 (Fluidigm). 569 
Imaging-mass cytometry 570 
Antibodies used for imaging-mass cytometry are listed in Supplementary Table 3. Purified antibodies 571 
lacking carrier protein were conjugated with metal reporters by using a MaxPar X8 Antibody 572 
Labeling Kit (Fluidigm). Snap-frozen human fetal intestinal biopsies were sectioned at a thickness of 573 
5 μm and fixed by incubating with 1% paraformaldehyde for 5 min at rT followed by 100% methanol 574 
for 5 min at –20 °C. After fixation, tissue sections were washed in Dulbecco’s phosphate-buffered 575 
saline (Thermo Fisher Scientific) containing 0.5% bovine serum albumin and 0.05% Tween, 576 
rehydrated in additive-free Dulbecco’s phosphate-buffered saline, washed again, and blocked with 577 
Superblock Solution (Thermo Fisher Scientific). Tissue sections were then stained with a cocktail of 578 
metal-conjugated antibodies overnight at 4 °C, washed, and incubated with 125 nM Cell-ID 579 
Intercalator-Ir for 30 min at rT. After a further wash, tissue sections were dipped in Milli-Q water 580 
(Merck Millipore) for 1 min and dried for 20 min at rT. Data were acquired using a HyperionTM 581 
imaging-mass cytometer (Fluidigm) at a resolution of 1 µm, with settings aligned to company 582 
guidelines. The ablation frequency was 200 Hz, and the energy was 6 dB. Regions of interest were 583 
acquired at a size of 1 by 1 mm2. All data were stored as MCD files and txt files. 584 
Single-cell RNA-sequencing 
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Single, live, CD8a–TCRγδ–CD4+ cells from the intestines of fetus #6 were sorted using a FACSAria 586 
III flow cytometer (BD Biosciences). Post-sort purity was 96.5%. Single-cell RNA-sequencing was 587 
performed as described previously42. Briefly, cells combined with oil, reagents, and beads were 588 
loaded on a Chromium Single Cell Controller (10x Genomics). Lysis and barcoded reverse 589 
transcription of polyadenylated mRNA from single cells were performed inside each gel bead 590 
emulsion. Next-generation sequencing libraries were prepared in a single bulk reaction, and 591 
transcripts were sequenced using a HiSeq4000 System (Illumina). 592 
Integrated data analysis  593 
For cell suspension-mass cytometry, data from single, live, CD45+ cells, gated individually using 594 
Cytobank as shown in Supplementary Fig. 1a, were sample-tagged and hyperbolic-arcsinh-595 
transformed with a cofactor of 5 using Cytosplore+HSNE software13. The major immune lineages shown 596 
in Supplementary Fig. 1b were then identified at the overview level by performing a 3-level HSNE 597 
analysis carried out with default parameters (perplexity: 30; iterations: 1,000). All t-SNE plots and 598 
Gaussian Mean-Shift clustering-derived cell clusters were generated in Cytosplore15. Hierarchical 599 
clustering of the phenotype heatmap was created with Euclidean correction and average linkage 600 
clustering in Cytosplore+HSNE. Violin plots for cytometry data were generated in R. Diffusion map 601 
plots for mass cytometry data were generated using the “density” package in R. Single-cell force-602 
directed layouts for mass cytometry data were generated using “VorteX” software19. For imaging-603 
mass cytometry, all images were generated using MCD Viewer software v1.0.560 (Fluidigm). For 604 
single-cell RNA-seq, single-cell transcriptome sequencing data were processed using the single-cell 605 
RNA-seq package “Seurat” in R16. The Seurat object was generated by following the criteria that each 606 
gene was expressed by at least 3 cells and that at least 200 genes were expressed per cell. Data were 607 
further filtered based on the parameters: (i) unique gene count per cell >200 and <2,000; and (ii) 608 
mitochondrial percentage of all genes <0.05. After log-normalization, a PCA-reduction analysis 609 
(pcs.compute = 20) was performed based on the 2,174 variable genes across single cells. Next, graph-610 
based clustering detection and a t-SNE algorithm were applied to the top 13 PCA-dimensions. The 611 
resolution for cluster detection was 0.8. Heatmaps, PCA plots, diffusion map plots, and violin plots of 612 
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the RNA-seq data were generated using the “Seurat” package. The t-SNE plots for RNA-seq data 613 
shown in Fig. 4b were generated in Cytosplore+HSNE. Only genes with local standardization (>0.5) 614 
across all cells were taken into account. Bar graphs and dot plots (showing mean and SD) were 615 
generated in Prism (GraphPad). The pseudotime analysis shown in Fig. 4c,d was performed using the 616 
Monocle 2 toolkit in R as described previously22, excluding unrelated Treg cells. Briefly, the single-cell 617 
trajectory was inferred using the dpFeature unsupervised procedure to identify variable genes, and the 618 
dimensions were reduced using t-SNE on the top high-loading principal components. The top 1,000 619 
significant genes were selected as the ordering genes and reduced with the DDRTree method for the 620 
single-cell graph shown in Fig. 4c. Variable genes were selected at a significant false discovery rate of 621 
<10%, clustered by pseudo-temporal expression patterns, and visualized in a heatmap in Fig. 4d. Gene 622 
list enrichment analysis was performed using ToppGene43, gene interaction network analysis was 623 
performed using the BioGrid interaction database44, and gene pathway analysis was performed using 624 
the Kyoto Encyclopedia of Genes and Genomes45. 625 
Flow cytometry 626 
For surface staining, cells were incubated with fluorochrome-conjugated antibodies and human Fc 627 
block (BioLegend) for 30–45 min at 4 °C. For intracellular cytokine/CD154 staining, cells were 628 
stimulated with CD3/CD28-specific (2.5 µg/mL each, BioLegend) or control antibodies (5 µg/mL, 629 
BioLegend) for 4 h at 37 °C. Brefeldin A (10 µg/mL, Sigma) was added for the final 3 h. Cells were 630 
then fixed/permeabilized using Fixation Buffer and Intracellular Staining Perm Wash Buffer 631 
(BioLegend). For intracellular Foxp3/Ki-67 staining, cells were prepared using a Foxp3 Staining 632 
Buffer Set (eBioscience). Electronic compensation was performed using individually stained 633 
CompBeads (BD Biosciences). Cells were acquired using an LSR II cytometer (BD Biosciences) or 634 
sorted using a FACSAria III flow cytometer (BD Biosciences) as shown in Supplementary Fig. 3a. 635 
Data were analyzed with FlowJo software v10 (Tree Star Inc.). The antibodies used in this study are 636 
listed in Supplementary Table 4. 637 
TCR repertoire analysis 638 
CD4+ T cell subsets were sorted according to the gating strategy shown in Supplementary Fig. 3a. For 639 
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conventional sequencing, a total of 5,000 cells per subset was sorted directly into RNAlater (Applied 640 
Biosystems) using a FACSAria III flow cytometer (BD Biosciences). All expressed TCRβ 641 
rearrangements were amplified using a template-switch anchored RT-PCR, sequenced, and analyzed 642 
as described previously46. Gene use was determined according to the ImMunoGeneTics (IMGT) 643 
nomenclature47.  644 
For high-throughput sequencing, an average of 6,700 ± 2,000 cells per subset was sorted directly into 645 
RLT buffer (Qiagen) using a FACSAria III flow cytometer (BD Biosciences). Four volumes of 646 
TRIzol (Invitrogen) were then added to the RLT cell lysate. RNA was extracted according to the 647 
TRIzol Reagent User Guide. Unique molecular identifier (UMI)-labelled 5’RACE TCRα and TCRβ 648 
cDNA libraries were prepared using a Human TCR Profiling Kit (MiLaboratory LLC). All extracted 649 
RNA was used for cDNA synthesis, and all synthesized cDNA was used for PCR amplification. 650 
Libraries were prepared in parallel using the same number of PCR cycles and sequenced in parallel 651 
using a 150 + 150 bp MiSeq System (Illumina). This approach generated a total of 11,310,000 TCRα 652 
and TCRβ sequencing reads (250,000 ± 150,000 reads per library), from which 625,000 unique 653 
unique UMI-labelled TCR cDNA molecules (13,500 ± 7,000 molecules per library) were extracted 654 
using MIGEC48 and MiXCR49 software with a threshold of at least 2 sequencing reads per UMI. Each 655 
library contained an average of 3,500 ± 1,300 functional (in-frame, without stop-codons) CDR3 656 
nucleotide sequences. Averaged TCR repertoire characteristics weighted by clonotype size were 657 
analyzed using VDJtools software27. Gene use was determined according to the ImMunoGeneTics 658 
(IMGT) nomenclature47. 659 
Statistics 660 
Results are shown as mean ± SEM. The statistics test used were two-tailed Wilcoxon matched-pairs 661 
signed-ranks test and Kruskal-Wallis test with Dunn’s test for multiple group comparisons, as 662 
appropriate (after normality test). P ≤ 0.05 was considered to be statistically significant. All statistics 663 
were analysed using GraphPad Prism 7 software. 664 
Reporting Summary 665 
Further information on research design is available in the Nature Research Life Sciences Reporting 666 
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Summary linked to this article. 667 
Data availability 668 
Mass cytometry data are available via Flow Repository (https://flowrepository.org/id/FR-FCM-669 
ZYRD). scRNA-seq data are available via Gene Expression Omnibus accession code GSE122846. 670 
The remaining data that support the findings of this study are available from the corresponding author 671 
upon reasonable request. 672 
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